CLINICAL TRIAL;
DRUG EFFICACY;
EDITORIAL;
HEALTH SURVEY;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H3N2;
INFLUENZA VIRUS B;
PREVALENCE;
PRIORITY JOURNAL;
TREATMENT INDICATION;
TREATMENT OUTCOME;
VACCINATION;
VIRUS STRAIN;
VIRUS TRANSMISSION;
ADULT;
HUMANS;
INFLUENZA A VIRUS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA A VIRUS, H3N2 SUBTYPE;
INFLUENZA B VIRUS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
MIDDLE AGED;
POPULATION SURVEILLANCE;
VACCINATION;
YOUNG ADULT;
Belongia EA, Kieke BA, Donahue JG, et al. Correlation between inactivated influenza vaccine effectiveness and antigenic match, from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67 (in this issue).
Belongia EA, Kieke BA, Donahue JG, et al. Correlation between inactivated influenza vaccine effectiveness and antigenic match, from the 2004-2005 season to the 2006-2007 season. J Infect Dis 2009; 199:159-67 (in this issue).
2
58849165403
Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79 (in this issue).
Skowronski DM, De Serres G, Dickinson J, et al. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis 2009; 199:168-79 (in this issue).
3
21244454932
Update: Influenza activity - United States and worldwide, 2004-05 season
Update: Influenza activity - United States and worldwide, 2004-05 season. MMWR Morb Mortal Wkly Rep 2005; 54:631-4.
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines
Ohmit SE, Victor JC, Teich ER, et al. Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis 2008; 198:312-7.
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
Ohmit SE, Victor JC, Rotthoff JR, et al. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22.
Update: Influenza activity - United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine
Update: influenza activity - United States and worldwide, 2005-06 season, and composition of the 2006-07 influenza vaccine. MMWR Morb Mortal Wkly Rep 2006; 55:648-53.
United States. Available at:, Accessed 25 September 2008
Centers for Disease Control and Prevention. Flu activity & surveillance: reports & surveillance methods in the United States. Available at: http://www.cdc.gov/flu/weekly/fluactivity.htm. Accessed 25 September 2008.
Mortality benefits of influenza vaccination in elderly people: An ongoing controversy
Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007; 7:658-66.
Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: A population-based, nested case-control study
Jackson ML, Nelson JC, Weiss NS, Neuzil KM, Barlow W, Jackson LA. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372:398-405.
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
McGeer A, Green KA, Plevneshi A, et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 2007; 45:1568-75.
